SenesTech to Participate in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024
SenesTech, Inc. (NASDAQ: SNES), the rodent fertility control experts, announced its participation in the Lytham Partners Fall 2024 Investor Conference on October 1, 2024. The company, known for inventing the only EPA registered contraceptive for male and female rats, will engage in two key activities:
1. A webcasted presentation at 11:00am ET, accessible via the conference homepage or a direct link. The webcast will be available for replay after the event.
2. Virtual one-on-one meetings with investors throughout the event. Interested parties can arrange meetings through Lytham Partners or by registering on the event website.
This virtual conference provides SenesTech an opportunity to showcase its innovative rodent fertility control solutions to potential investors and industry professionals.
SenesTech, Inc. (NASDAQ: SNES), esperti nel controllo della fertilità dei roditori, ha annunciato la sua partecipazione alla Conferenza degli Investitori Lytham Partners Fall 2024 il 1 ottobre 2024. L'azienda, nota per aver inventato l'unico contraccettivo registrato dalla EPA per ratti maschi e femmine, parteciperà a due attività chiave:
1. Una presentazione in webcast alle 11:00 ET, accessibile tramite la homepage della conferenza o un link diretto. Il webcast sarà disponibile per una replica dopo l'evento.
2. Incontri virtuali individuali con gli investitori durante tutto l'evento. Le parti interessate possono organizzare incontri tramite Lytham Partners o registrandosi sul sito web dell'evento.
Questa conferenza virtuale offre a SenesTech l'opportunità di mostrare le sue soluzioni innovative per il controllo della fertilità dei roditori a potenziali investitori e professionisti del settore.
SenesTech, Inc. (NASDAQ: SNES), expertos en el control de la fertilidad de roedores, anunció su participación en la Conferencia de Inversores Lytham Partners Fall 2024 el 1 de octubre de 2024. La compañía, reconocida por inventar el único anticonceptivo registrado por la EPA para ratas machos y hembras, se involucrará en dos actividades clave:
1. Una presentación transmitida por webcast a las 11:00 a. m. ET, accesible a través de la página principal de la conferencia o mediante un enlace directo. El webcast estará disponible para su reproducción tras el evento.
2. Reuniones virtuales uno a uno con inversionistas durante todo el evento. Las partes interesadas pueden organizar reuniones a través de Lytham Partners o registrándose en el sitio web del evento.
Esta conferencia virtual ofrece a SenesTech la oportunidad de mostrar sus innovadoras soluciones de control de la fertilidad de roedores a potenciales inversionistas y profesionales de la industria.
SenesTech, Inc. (NASDAQ: SNES), 설치류의 생식 통제 전문가, 2024년 가을 Lytham Partners 투자자 컨퍼런스에 참석한다고 발표했습니다. 2024년 10월 1일에 열리는 이 행사에서, 남성과 여성 쥐를 위한 유일한 EPA 등록 피임약을 발명한 회사가 두 가지 주요 활동에 참여할 것입니다:
1. 11:00am ET에 웹캐스트 발표가 진행되며, 컨퍼런스 홈페이지나 직접 링크를 통해 접근할 수 있습니다. 이 웹캐스트는 행사 후 재생이 가능할 것입니다.
2. 행사 기간 동안 투자자와의 가상 일대일 미팅이 진행됩니다. 관심 있는 분들은 Lytham Partners를 통해 미팅을 조정하거나 행사 웹사이트에서 등록할 수 있습니다.
이번 가상 컨퍼런스는 SenesTech에게 잠재 투자자 및 업계 전문가에게 혁신적인 설치류 생식 통제 솔루션을 선보일 수 있는 기회를 제공합니다.
SenesTech, Inc. (NASDAQ: SNES), experts en contrôle de la fertilité des rongeurs, a annoncé sa participation à la Conférence des Investisseurs Lytham Partners Fall 2024 le 1er octobre 2024. L'entreprise, connue pour avoir inventé le seul contraceptif enregistré par l'EPA pour les rats mâles et femelles, participera à deux activités clés :
1. Une présentation en webcast à 11h00 ET, accessible via la page d'accueil de la conférence ou un lien direct. Le webcast sera disponible en replay après l'événement.
2. Réunions virtuelles en tête-à-tête avec des investisseurs tout au long de l'événement. Les parties intéressées peuvent organiser des rencontres via Lytham Partners ou en s'inscrivant sur le site de l'événement.
Cette conférence virtuelle offre à SenesTech l'opportunité de présenter ses solutions innovantes de contrôle de la fertilité des rongeurs à des investisseurs et professionnels de l'industrie potentiels.
SenesTech, Inc. (NASDAQ: SNES), die Experten für die Kontrolle der Fortpflanzung von Nagetieren, gab seine Teilnahme an der Lytham Partners Fall 2024 Investor Conference am 1. Oktober 2024 bekannt. Das Unternehmen, das für die Erfindung des einzigen von der EPA registrierten Verhütungsmittels für männliche und weibliche Ratten bekannt ist, wird an zwei wichtigen Aktivitäten teilnehmen:
1. Eine Webcast-Präsentation um 11:00 Uhr ET, die über die Konferenz-Homepage oder einen direkten Link zugänglich ist. Der Webcast wird nach der Veranstaltung zur Wiedergabe verfügbar sein.
2. Virtuelle Einzelgespräche mit Investoren während der gesamten Veranstaltung. Interessierte Parteien können Treffen über Lytham Partners anfragen oder sich auf der Veranstaltungswebsite registrieren.
Diese virtuelle Konferenz bietet SenesTech die Möglichkeit, potenziellen Investoren und Fachleuten der Branche seine innovativen Lösungen zur Kontrolle der Fortpflanzung von Nagetieren vorzustellen.
- None.
- None.
The webcasted presentation will take place at 11:00am ET on Tuesday, October 1, 2024. The webcast can be accessed by visiting the conference home page at https://lythampartners.com/fall2024/ or directly at https://app.webinar.net/yOrYbRyQg8o. The webcast will also be available for replay following the event.
Management will be participating in virtual one-on-one meetings throughout the event. To arrange a meeting with management, please contact Lytham Partners at 1x1@lythampartners.com or register for the event at https://lythampartners.com/fall2024invreg/.
We are committed to improving the health of the world by humanely managing animal pest populations through our expertise in fertility control. We invented ContraPest, the only
For more information visit https://senestech.com/.
This press release contains "forward-looking statements" within the meaning of federal securities laws, and we intend that such forward-looking statements be subject to the safe harbor created thereby. Forward-looking statements may describe future expectations, plans, results or strategies and are often, but not always, made through the use of words such as "believe," "may," "future," "plan," "will," "should," "expect," "anticipate," "eventually," "project," "estimate," "continuing," "intend" and similar words or phrases. You are cautioned that such statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those reflected by such forward-looking statements. Such factors include, among others, the successful commercialization of our products; market acceptance of our products; our financial performance, including our ability to fund operations; our ability to regain and maintain compliance with Nasdaq's continued listing requirements; and regulatory approval and regulation of our products and other factors and risks identified from time to time in our filings with the Securities and Exchange Commission, including our Annual Report on Form 10-K for the fiscal year ended December 31, 2023. All forward-looking statements contained in this press release speak only as of the date on which they were made and are based on management's assumptions and estimates as of such date. Except as required by law, we do not undertake any obligation to publicly update any forward-looking statements, whether as a result of the receipt of new information, the occurrence of future events or otherwise.
CONTACT:
Investor: Robert Blum, Lytham Partners, LLC, 602-889-9700, senestech@lythampartners.com
Company: Tom Chesterman, Chief Financial Officer, SenesTech, Inc., 928-779-4143
View original content to download multimedia:https://www.prnewswire.com/news-releases/senestech-to-participate-in-the-lytham-partners-fall-2024-investor-conference-on-october-1-2024-302255006.html
SOURCE SenesTech, Inc.
FAQ
When is SenesTech (SNES) participating in the Lytham Partners Fall 2024 Investor Conference?
What time is SenesTech's (SNES) webcasted presentation at the Lytham Partners conference?
How can investors access SenesTech's (SNES) webcast presentation at the Lytham Partners conference?
Will SenesTech (SNES) be available for one-on-one meetings during the Lytham Partners conference?
How can investors arrange a one-on-one meeting with SenesTech (SNES) during the Lytham Partners conference?
